iBusiness
  • Home
  • Top News
    • South Africa
    • Powerball
    • Lotto
    • SA Daily Lotto
    • Opinion
    • Motoring
    • Economy
    • Tech
  • Business
    • Business Banking
    • Business Finance
  • Personal Finance
    • Banking
      • Capitec Bank
      • ABSA
      • FNB
      • African Bank
      • Nedbank
      • Standard Bank
      • Other Banks
    • Investing
    • Loans
    • Taxes
  • Forex Trading
    • Beginner’s Guide
    • Regulated Brokers
  • Website Hosting
  • SA Networks
    • Cell C
    • Vodacom
    • MTN
    • Telkom
  • Insurance
No Result
View All Result
  • Home
  • Top News
    • South Africa
    • Powerball
    • Lotto
    • SA Daily Lotto
    • Opinion
    • Motoring
    • Economy
    • Tech
  • Business
    • Business Banking
    • Business Finance
  • Personal Finance
    • Banking
      • Capitec Bank
      • ABSA
      • FNB
      • African Bank
      • Nedbank
      • Standard Bank
      • Other Banks
    • Investing
    • Loans
    • Taxes
  • Forex Trading
    • Beginner’s Guide
    • Regulated Brokers
  • Website Hosting
  • SA Networks
    • Cell C
    • Vodacom
    • MTN
    • Telkom
  • Insurance
No Result
View All Result
iBusiness
No Result
View All Result
Home Top News

WHO: Hydroxychloroquine and lopinavir/ritonavir treatment arms for COVID-19 discontinued

iBusiness Staff by iBusiness Staff
July 4, 2020
in Top News
0
WHO: Hydroxychloroquine and lopinavir/ritonavir treatment arms for COVID-19 discontinued

WHO emblem logo

0
SHARES
0
VIEWS
Share on FacebookShare on Twitter

WHO has released a statement confirming that it has accepted Solidarity Trial’s International Steering Committee’s recommendation to halt the trial’s hydroxychloroquine and lopinavir/ritonavir arms.

WHO established the Solidarity Trial to find an effective COVID-19 treatment for patients in critical conditions/hospitalized.

This recommendation came in light of the evidence for hydroxychloroquine vs standard-of-care as well as for lopinavir/ritonavir vs standard-of-care – from this review, the trial results produce little to no reduction in the mortality of COVID-19 patients who have been hospitalized as compared to the standard of care.

WHO also confirms that the ‘decision applies only to the conduct of the Solidarity trial in hospitalized patients and does not affect the possible evaluation in other studies of hydroxychloroquine or lopinavir/ritonavir in non-hospitalized patients or as pre- or post-exposure prophylaxis for COVID-19’

Source: WHO[Media Release]

iBusiness Staff

iBusiness Staff

Related Posts

Tech

Netflix Wants To Charge A Fee For Sharing Accounts

March 17, 2022 - Updated on March 18, 2022
South Africa

South Africa Requested To Mediate In Ending Russia – Ukraine War

March 10, 2022
Markets

Fears Of Heightened Inflation Due To Oil Price Spike

March 9, 2022
Next Post
Daily Lotto Results

Daily Lotto Results for Sunday, 5 July 2020

Gomora Drama Teasers

All-new episodes on Gomora, see teasers for July 2020

Isibaya teasers

Ntwenhle’s pregnancy on Isibaya, see teasers for July 2020

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

Recommended

Telkom Monthly Recurring Data Bundles

3 years ago

Handling risks in Forex and making a trading plan

3 years ago
lotto Results

Lotto Results, Wednesday 04 March 2020

2 years ago

Daily Lotto Results: Thursday, 05 May 2022

2 months ago

Topics

#business #businessnews #Corruption #covid-19 #Covid19 #currentaffairs #DailyLotto #daily lotto results #DailyMarketWrap #Economy #equitymarkets #finance #Financialmarkets #FSCA #funding #Globalmarkets #Inflation #investments #JSE #loadshedding #lockdown #lotto #lottoresults #marketnews #personalfinance #petrolpricehike #powerball #powercuts #Sassa #Sassacares #Sassa grants #SouthAfrica #stockmarket business Coronavirus in South Africa daily lotto results daily lotto winning numbers Data Bundles Eskom Finances Life Insurance Load-Shedding lotto winning numbers SASSA News Visa
No Result
View All Result

Highlights

Powerball and Powerball plus results, Tuesday 28 June 2022

Daily Lotto Results: Monday, 27 June 2022

See the Binnelanders Teasers for July 2022

Missing out on the drama? See Scandal! Teasers for July 2022

Don’t miss the Elif 3 Teasers for July 2022

The unpredictable Droomverlore continues, see Teasers for July 2022

Trending

SA Daily Lotto

Daily Lotto Results: Sunday, 03 July 2022

by iBusiness Staff
July 3, 2022
0

Are you ready for tonight’s daily results for Sunday, 03 July 2022. The winning numbers will be...

Daily Lotto Results: Thursday, 30 June 2022

June 30, 2022

Daily Lotto Results: Tuesday, 28 June 2022

June 28, 2022
Powerball Results

Powerball and Powerball plus results, Tuesday 28 June 2022

June 28, 2022

Daily Lotto Results: Monday, 27 June 2022

June 27, 2022
ADVERTISEMENT

iBusiness




iBusiness is a fully packaged business portal, that aims to add as much important information as possible. It is a business portal website – and the “i” in iBusiness doesn't necessarily stand for anything but can represent the innovative ideas spread across the website.





  • Disclaimer
  • Cookie Policy
  • About
  • Contact
  • Terms and Conditions
  • Privacy Policy
  • Economic Calendar

© 2021 iBusiness.co.za - Designed for Business News

No Result
View All Result
  • Home
  • Top News
    • South Africa
    • Powerball
    • Lotto
    • SA Daily Lotto
    • Opinion
    • Motoring
    • Economy
    • Tech
  • Business
    • Business Banking
    • Business Finance
  • Personal Finance
    • Banking
      • Capitec Bank
      • ABSA
      • FNB
      • African Bank
      • Nedbank
      • Standard Bank
      • Other Banks
    • Investing
    • Loans
    • Taxes
  • Forex Trading
    • Beginner’s Guide
    • Regulated Brokers
  • Website Hosting
  • SA Networks
    • Cell C
    • Vodacom
    • MTN
    • Telkom
  • Insurance

© 2021 iBusiness is a fully packaged business portal, that aims to add as much important information as possible. It is a business portal website – and the “i” in iBusiness doesn't necessarily stand for anything but can represent the innovative ideas spread across the website.

This website uses cookies. By continuing to use this website you are giving consent to cookies being used. Visit our Privacy and Cookie Policy.